Skip to content

HORUS: Health Outcomes from Raised Urban Settings

Evaluating the Health Outcomes from Raised Urban Settings (HORUS) intervention in the Rotterdam pilot site - PILOT-HORUS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58231
Enrollment
300
Registered
2025-07-29
Start date
2026-01-13
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes, Cardiovascular Diseases (CVDs) Diabetes, heart disease

Interventions

Participants assigned to the intervention condition will receive the HORUS intervention. This includes a structured assessment, using self-reported questionnaires to evaluate lifestyle, self-efficacy,

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a participant must meet all of the following criteria:are aged 18 years or older, are at risk for non-communicable diseases (NCDs) or have a diagnosis of type 2 diabetes and/or cardiovascular disease (CVD), reside in selected neighborhoods,are capable of providing informed consent, and have comprehension of the local language. 

Exclusion criteria

Exclusion criteria: A potential participant who meets any of the following criteria will be excluded from participation in this study:reside outside the selected neighborhoods, are unable to adequately engage with intervention activities due to factors such as severe physical and intellectual disabilities, and language barriers, or are unwilling to provide informed consent.

Design outcomes

Primary

MeasureTime frame
The main study parameters for the impact evaluation are outcomes related to lifestyle, including diet, physical activity, alcohol consumption, and smoking. Study parameters for the implementation evaluation are acceptability, appropriateness, feasibility, adoption, penetration, implementation costs and sustainability.

Secondary

MeasureTime frame
In addition to self-reported data collected through questionnaires, objective data will be gathered through mobile-based sensors in both the intervention and the control group. 

Countries

Croatia, Netherlands, Spain

Contacts

Public ContactA Grieken

Erasmus MC, Universitair Medisch Centrum Rotterdam

a.vangrieken@erasmusmc.nl0107039163

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026